View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
May 19, 2022

Medical Devices industry cross border deals total $3bn globally in April 2022

By Carmen

Total medical devices industry cross border deals worth $3bn were announced globally for April 2022, with the $1.2bn private equity deal with Natus Medical being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 114.3% over the previous month of $1.4bn and a drop of 57.1% when compared with the last 12-month average of $7bn.

In terms of number of cross border deals, the sector saw a drop of 32.79% with 41 deals in April 2022 when compared to the last 12-month average of 61 deals.

In value terms, North America led the activity with cross border deals worth $1.9bn in April 2022.

medical devices industry cross border deals in April 2022: Top deals

The top five cross border deals accounted for 77.9% of the overall value during April 2022.

The combined value of the top five cross border deals stood at $2.33bn, against the overall value of $3bn recorded for the month.

The top five medical devices industry cross border deals of April 2022 tracked by GlobalData were:

1) ArchiMed $1.2bn private equity deal with Natus Medical

2) The $541.63m acquisition of Phenox by Wallaby Medical

3) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis

4) The $150m venture financing of BostonGene by Impact Investment Partners,Japan Industrial Partners and NEC

5) Integer $141.73m acquisition deal with Aran Biomedical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network